T1 Mapping of the Gadolinium-Enhanced Myocardium: Adjustment for Factors Affecting Interpatient Comparison

被引:100
作者
Gai, Neville [1 ,2 ]
Turkbey, Evrim B. [1 ,2 ]
Nazarian, Saman [3 ]
van der Geest, Rob J. [4 ]
Liu, Chia-Ying [5 ]
Lima, Joao A. C. [3 ,5 ]
Bluemke, David A. [1 ,2 ,5 ]
机构
[1] NIH, Ctr Clin, Bethesda, MD 20892 USA
[2] Natl Inst Biomed Imaging & Bioengn, NIH, Bethesda, MD USA
[3] Johns Hopkins Univ, Sch Med, Dept Med, Div Cardiol, Baltimore, MD 21205 USA
[4] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands
[5] Johns Hopkins Univ, Sch Med, Dept Radiol & Radiol Sci, Baltimore, MD USA
关键词
T-1; mapping; myocardial fibrosis; patient T-1 comparison; GFR; delayed enhancement; GLOMERULAR-FILTRATION-RATE; DELAYED-ENHANCEMENT; CONTRAST; MRI; ATHEROSCLEROSIS; VISUALIZATION; INJECTION; EXTENT; BLOOD; TIME;
D O I
10.1002/mrm.22716
中图分类号
R8 [特种医学]; R445 [影像诊断学];
学科分类号
1002 ; 100207 ; 1009 ;
摘要
Quantitative T-1 mapping of delayed gadolinium-enhanced cardiac magnetic resonance imaging has shown promise in identifying diffuse myocardial fibrosis. Despite careful control of magnetic resonance imaging parameters, comparison of T-1 times between different patients may be problematic because of patient specific factors such as gadolinium dose, differing glomerular filtration rates, and patient specific delay times. In this work, a model driven approach to account for variations between patients to allow for comparison of T-1 data is provided. Kinetic model parameter values were derived from healthy volunteer time-contrast curves. Correction values for the factors described above were used to normalize T-1 values to a matched state. Examples of pre- and postcorrected values for a pool of normal subjects and in a patient cohort of type 1 diabetic patients shows tighter clustering and improved discrimination of disease state. Magn Reson Med 65:1407-1415, 2011. (C) 2010 Wiley-Liss, Inc.
引用
收藏
页码:1407 / 1415
页数:9
相关论文
共 33 条
[1]   Standards of Medical Care in Diabetes-2009 [J].
不详 .
DIABETES CARE, 2009, 32 :S13-S61
[2]   Multi-ethnic study of atherosclerosis: Objectives and design [J].
Bild, DE ;
Bluemke, DA ;
Burke, GL ;
Detrano, R ;
Roux, AVD ;
Folsom, AR ;
Greenland, P ;
Jacobs, DR ;
Kronmal, R ;
Liu, K ;
Nelson, JC ;
O'Leary, D ;
Saad, MF ;
Shea, S ;
Szklo, M ;
Tracy, RP .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2002, 156 (09) :871-881
[3]   Quantitative assessment of glomerular filtration rate with MR gadolinium slope clearance measurements:: A phase I trial [J].
Boss, Andreas ;
Martirosian, Petros ;
Gehrmann, Michael ;
Artunc, Ferruh ;
Risler, Teut ;
Oesingmann, Niels ;
Claussen, Claus D. ;
Schick, Fritz ;
Kueper, Klaus ;
Schlemmer, Heinz-Peter .
RADIOLOGY, 2007, 242 (03) :783-790
[4]  
Delaney JAC, 2009, CAN J CARDIOL, V25, pE232
[5]  
Foley RN, 1998, J AM SOC NEPHROL, V9, P267
[6]   Clinical epidemiology of cardiovascular disease in chronic renal disease [J].
Foley, RN ;
Parfrey, PS ;
Sarnak, MJ .
AMERICAN JOURNAL OF KIDNEY DISEASES, 1998, 32 (05) :S112-S119
[7]  
Genuth S, 1999, DIABETES CARE, V22, P99
[8]  
Genuth S, 2007, NEW ENGL J MED, V356, P1842
[9]   Magnetic resonance imaging in the evaluation of non-ischemic cardiomyopathies: Current applications and future perspectives [J].
Gottlieb, Ilan ;
Macedo, Robson ;
Bluemke, David A. ;
Lima, Joao A. C. .
HEART FAILURE REVIEWS, 2006, 11 (04) :313-323
[10]   Gadobutrol, a highly concentrated MR-imaging contrast agent,agent its physicochemical characteristics and the basis for its use in contrast-enhanced MR angiography and perfusion imaging [J].
Huppertz, A ;
Rohrer, M .
EUROPEAN RADIOLOGY, 2004, 14 :M12-M18